Sernova Biotherapeutics Inc (TSX:SVA)
Canada · Delayed Price · Currency is CAD 0.1450
0.00 (0.00%)
At close: Feb 11, 2026
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of CAD 49.17 million as of February 11, 2026. Its market cap has decreased by -21.22% in one year.
Market Cap
49.17M
Enterprise Value
53.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 17.04M to 49.17M, an increase of 188.61%. That is a compound annual growth rate of 4.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 49.17M | 12.34% |
| Dec 31, 2025 | 43.77M | -40.78% |
| Dec 31, 2024 | 73.91M | -67.09% |
| Dec 29, 2023 | 224.60M | -3.01% |
| Dec 30, 2022 | 231.57M | -51.28% |
| Dec 31, 2021 | 475.26M | 238.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 68.21M |
| Medicenna Therapeutics | 66.74M |
| Sharp Therapeutics | 66.17M |
| NurExone Biologic | 58.04M |
| MedMira | 45.33M |
| BriaCell Therapeutics | 35.96M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 33.09M |